Vistagen Therapeutics, Inc. (VTGN) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $1.09M2022: $1.11M2024: $1.06M2025: $486.0K2026: $1.27M$1.27M
2021Revenue (USD)2026
Fiscal YearRevenueChange YoY
2026$1.27M+161.1%
2025$486.0K-54.3%
2024$1.06M
2022$1.11M+1.8%
2021$1.09M